TrialDrug design, development and therapy2024

Intravenous Odatroltide for Acute Ischemic Stroke Within 24 Hours of Onset: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study.

A-Ching Chao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.